These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35681715)

  • 21. Evidence from a leukemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells.
    Gunsilius E
    Adv Exp Med Biol; 2003; 522():17-24. PubMed ID: 12674207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A hybrid model of tumor growth and angiogenesis: In silico experiments.
    Phillips CM; Lima EABF; Woodall RT; Brock A; Yankeelov TE
    PLoS One; 2020; 15(4):e0231137. PubMed ID: 32275674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells.
    Xiong YQ; Sun HC; Zhang W; Zhu XD; Zhuang PY; Zhang JB; Wang L; Wu WZ; Qin LX; Tang ZY
    Clin Cancer Res; 2009 Aug; 15(15):4838-46. PubMed ID: 19638466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
    Leite de Oliveira R; Hamm A; Mazzone M
    Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-3 is a novel target to interfere with tumor vasculature.
    Dentelli P; Rosso A; Olgasi C; Camussi G; Brizzi MF
    Oncogene; 2011 Dec; 30(50):4930-40. PubMed ID: 21643009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of normal and tumor-derived angiogenesis.
    Papetti M; Herman IM
    Am J Physiol Cell Physiol; 2002 May; 282(5):C947-70. PubMed ID: 11940508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio.
    van Gisbergen MW; Zwilling E; Dubois LJ
    Front Oncol; 2021; 11():653621. PubMed ID: 34041023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normalization of the vasculature for treatment of cancer and other diseases.
    Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
    Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy.
    Denekamp J
    Br J Radiol; 1993 Mar; 66(783):181-96. PubMed ID: 7682469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature.
    Petrillo S; Tolosano E; Munaron L; Genova T
    Recent Pat Anticancer Drug Discov; 2018; 13(4):422-427. PubMed ID: 29807523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate.
    Godoy AS; Chung I; Montecinos VP; Buttyan R; Johnson CS; Smith GJ
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(11):E1131-9. PubMed ID: 23548616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial cell metabolism: parallels and divergences with cancer cell metabolism.
    Verdegem D; Moens S; Stapor P; Carmeliet P
    Cancer Metab; 2014; 2():19. PubMed ID: 25250177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis.
    Matsuda Y; Hagio M; Ishiwata T
    World J Gastroenterol; 2013 Jan; 19(1):42-8. PubMed ID: 23326161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency.
    Kutova OM; Guryev EL; Sokolova EA; Alzeibak R; Balalaeva IV
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30634580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of Tumor Endothelial Cells in Cancer Progression.
    Hida K; Maishi N; Annan DA; Hida Y
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting mTOR and Metabolism in Cancer: Lessons and Innovations.
    Magaway C; Kim E; Jacinto E
    Cells; 2019 Dec; 8(12):. PubMed ID: 31817676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature.
    Hooglugt A; van der Stoel MM; Boon RA; Huveneers S
    Front Oncol; 2020; 10():612802. PubMed ID: 33614496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific targeting of tumor vasculature by diphtheria toxin-vascular endothelial growth factor fusion protein reduces angiogenesis and growth of pancreatic cancer.
    Hotz HG; Gill PS; Masood R; Hotz B; Buhr HJ; Foitzik T; Hines OJ; Reber HA
    J Gastrointest Surg; 2002; 6(2):159-66; discussion 166. PubMed ID: 11992800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.